ArticleOpen medicine (Warsaw, Poland)2023

Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase.

Ruimin Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.